Ergomed appoints Mark Enyedy as Non-Executive Director | 10 May 2021
10 May 2021 | 15:25pm StockMarketWire.com - Pharmaceutical services company Ergomed plc announced Mark Enyedy will join the board as a non-executive director with effect from 10 June 2021. Enyedy has extensive knowledge of the biopharmaceutical sector brining more than 25 years of senior experience serving in various executive capacities across multiple therapeutic areas with a focus on rare diseases and oncology. Dr Miroslav Reljanović, executive chairman of Ergomed, said: 'Over the past 20 years, he has been strongly focused on rare disease and oncology, and brings to Ergomed exceptiona...